Graves Kurt has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 100000 shares of Seres Therapeutics, Inc. ($MCRB) on April 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 10, 2025 | Seres Therapeutics, Inc. | $MCRB | Graves Kurt | Not found | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 174,358,753 | 9999.99% | 0.06% |
| July 1, 2024 | Seres Therapeutics, Inc. | $MCRB | Graves Kurt | Not found | A | Stock Option (right to buy) | 64564 | $0.00 | 64,564.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2024 | Seres Therapeutics, Inc. | $MCRB | Graves Kurt | Not found | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Seres Therapeutics, Inc. | $MCRB | Graves Kurt | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |